{"analyses":[{"ciLowerLimit":"0.58","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.62","groupDescription":"Emotional Functioning, Presurgical/Surgery","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9096","paramType":"Odds Ratio (OR)","paramValue":"0.97","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.73","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.01","groupDescription":"Emotional functioning, Cycle 4 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4662","paramType":"Odds Ratio (OR)","paramValue":"1.21","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.51","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.40","groupDescription":"Emotional functioning, Cycle 6 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.5237","paramType":"Odds Ratio (OR)","paramValue":"0.85","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.76","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.07","groupDescription":"Emotional functioning, Cycle 8 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.3826","paramType":"Odds Ratio (OR)","paramValue":"1.25","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.56","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.76","groupDescription":"Emotional Functioning, Cycle 12 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9893","paramType":"Odds Ratio (OR)","paramValue":"1.00","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.49","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.61","groupDescription":"Emotional Functioning, Cycle 16 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6892","paramType":"Odds Ratio (OR)","paramValue":"0.89","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.17","groupDescription":"Emotional Functioning, Cycle 20 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1324","paramType":"Odds Ratio (OR)","paramValue":"0.59","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.62","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.70","groupDescription":"Emotional Functioning, Completion of Treatment/Early Termination Visit","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9176","paramType":"Odds Ratio (OR)","paramValue":"1.03","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.50","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.68","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 3 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7861","paramType":"Odds Ratio (OR)","paramValue":"0.92","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.65","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.65","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 6 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4539","paramType":"Odds Ratio (OR)","paramValue":"1.31","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.27","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.86","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 9 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4849","paramType":"Odds Ratio (OR)","paramValue":"0.71","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.19","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"3.34","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 12 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7470","paramType":"Odds Ratio (OR)","paramValue":"0.79","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-44.86","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 18 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0896","paramType":"Difference in Proportion of Responders","paramValue":"33.33","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-94.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Emotional Functioning, Post-Treatment Follow Up 24 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","paramType":"Difference in Proportion of Responders","paramValue":"50.00"},{"ciLowerLimit":"0.56","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.50","groupDescription":"Physical Functioning, Presurgical/Surgery","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7347","paramType":"Odds Ratio (OR)","paramValue":"0.92","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.32","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.00","groupDescription":"Physical Functioning, Cycle 4 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0479","paramType":"Odds Ratio (OR)","paramValue":"0.56","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.36","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.05","groupDescription":"Physical Functioning, Cycle 6 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0712","paramType":"Odds Ratio (OR)","paramValue":"0.61","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.56","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.58","groupDescription":"Physical Functioning, Cycle 8 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.8168","paramType":"Odds Ratio (OR)","paramValue":"0.94","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.50","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.52","groupDescription":"Physical Functioning, Cycle 12 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6417","paramType":"Odds Ratio (OR)","paramValue":"0.88","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.53","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.72","groupDescription":"Physical Functioning, Cycle 16 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.8821","paramType":"Odds Ratio (OR)","paramValue":"0.96","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.32","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.30","groupDescription":"Physical Functioning, Cycle 20 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.2158","paramType":"Odds Ratio (OR)","paramValue":"0.64","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.51","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.37","groupDescription":"Physical Functioning, Completion of Treatment/Early Termination Visit","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.4762","paramType":"Odds Ratio (OR)","paramValue":"0.84","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.61","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.96","groupDescription":"Physical Functioning, Post-Treatment Follow Up 3 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7585","paramType":"Odds Ratio (OR)","paramValue":"1.10","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.52","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.93","groupDescription":"Physical Functioning, Post-Treatment Follow Up 6 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9985","paramType":"Odds Ratio (OR)","paramValue":"1.00","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.85","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"5.06","groupDescription":"Physical Functioning, Post-Treatment Follow Up 9 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1067","paramType":"Odds Ratio (OR)","paramValue":"2.07","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.36","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"5.61","groupDescription":"Physical Functioning, Post-Treatment Follow Up 12 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6171","paramType":"Odds Ratio (OR)","paramValue":"1.42","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.08","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"23.57","groupDescription":"Physical Functioning, Post-Treatment Follow Up 18 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.8084","paramType":"Odds Ratio (OR)","paramValue":"1.41","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-100.00","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"94.30","groupDescription":"Physical Functioning, Post-Treatment Follow Up 24 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.3173","paramType":"Difference in Proportion of Responders","paramValue":"-50.00","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.69","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.77","groupDescription":"Global health status/QoL, Presurgical/Surgery","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6802","paramType":"Odds Ratio (OR)","paramValue":"1.10","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.48","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.29","groupDescription":"Global health status/QoL, Cycle 4 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.3470","paramType":"Odds Ratio (OR)","paramValue":"0.79","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.53","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.41","groupDescription":"Global health status/QoL, Cycle 6 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.5564","paramType":"Odds Ratio (OR)","paramValue":"0.86","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.72","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.99","groupDescription":"Global health status/QoL, Cycle 8 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.5000","paramType":"Odds Ratio (OR)","paramValue":"1.19","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.57","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.78","groupDescription":"Global health status/QoL, Cycle 12 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9778","paramType":"Odds Ratio (OR)","paramValue":"1.01","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.65","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.12","groupDescription":"Global health status/QoL, Cycle 16 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6005","paramType":"Odds Ratio (OR)","paramValue":"1.17","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.50","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.00","groupDescription":"Global health status/QoL, Cycle 20 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9900","paramType":"Odds Ratio (OR)","paramValue":"1.00","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.81","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.15","groupDescription":"Global health status/QoL, Completion of Treatment/Early Termination Visit","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.2634","paramType":"Odds Ratio (OR)","paramValue":"1.32","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.56","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.74","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 3 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9640","paramType":"Odds Ratio (OR)","paramValue":"0.99","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.40","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.46","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 6 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4117","paramType":"Odds Ratio (OR)","paramValue":"0.76","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.63","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"3.62","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 9 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.3505","paramType":"Odds Ratio (OR)","paramValue":"1.51","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.55","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"9.45","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 12 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.2439","paramType":"Odds Ratio (OR)","paramValue":"2.28","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-44.86","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 18 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1573","paramType":"Difference in Proportion of Responders","paramValue":"33.33","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-94.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Global health status/QoL, Post-Treatment Follow Up 24 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","paramType":"Difference in Proportion of Responders","paramValue":"50.00"},{"ciLowerLimit":"0.45","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.16","groupDescription":"Role Functioning, Presurgical/Surgery","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1820","paramType":"Odds Ratio (OR)","paramValue":"0.72","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.28","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"0.80","groupDescription":"Role functioning, Cycle 4 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0046","paramType":"Odds Ratio (OR)","paramValue":"0.47","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.36","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"0.97","groupDescription":"Role functioning, Cycle 6 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0361","paramType":"Odds Ratio (OR)","paramValue":"0.59","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.39","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.06","groupDescription":"Role functioning, Cycle 8 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.0848","paramType":"Odds Ratio (OR)","paramValue":"0.64","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.37","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.13","groupDescription":"Role functioning, Cycle 12 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1224","paramType":"Odds Ratio (OR)","paramValue":"0.64","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.41","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.33","groupDescription":"Role functioning, Cycle 16 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.3127","paramType":"Odds Ratio (OR)","paramValue":"0.74","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.42","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.65","groupDescription":"Role functioning, Cycle 20 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6065","paramType":"Odds Ratio (OR)","paramValue":"0.84","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.45","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.20","groupDescription":"Role functioning, Completion of Treatment/ Early Termination Visit","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.2173","paramType":"Odds Ratio (OR)","paramValue":"0.74","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.35","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.15","groupDescription":"Role functioning, Post-Treatment Follow Up 3 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1316","paramType":"Odds Ratio (OR)","paramValue":"0.64","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.46","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.76","groupDescription":"Role functioning, Post-Treatment Follow Up 6 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7678","paramType":"Odds Ratio (OR)","paramValue":"0.90","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.34","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.14","groupDescription":"Role functioning, Post-Treatment Follow Up 9 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7331","paramType":"Odds Ratio (OR)","paramValue":"0.85","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.73","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"10.92","groupDescription":"Role functioning, Post-Treatment Follow Up 12 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1235","paramType":"Odds Ratio (OR)","paramValue":"2.83","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-84.09","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"84.09","groupDescription":"Role functioning, Post-Treatment Follow Up 18 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","paramType":"Difference in Proportion of Responders","paramValue":"0.00"},{"ciLowerLimit":"-94.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Role functioning, Post-Treatment Follow Up 24 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","paramType":"Difference in Proportion of Responders","paramValue":"50.00"},{"ciLowerLimit":"0.65","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.78","groupDescription":"Social functioning, Presurgical/Surgery","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7869","paramType":"Odds Ratio (OR)","paramValue":"1.07","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.43","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.25","groupDescription":"Social functioning, Cycle 4 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.2502","paramType":"Odds Ratio (OR)","paramValue":"0.73","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.50","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.41","groupDescription":"Social functioning, Cycle 6 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.5066","paramType":"Odds Ratio (OR)","paramValue":"0.84","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.56","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.59","groupDescription":"Social functioning, Cycle 8 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.8124","paramType":"Odds Ratio (OR)","paramValue":"0.94","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.70","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.17","groupDescription":"Social functioning, Cycle 12 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4656","paramType":"Odds Ratio (OR)","paramValue":"1.23","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.62","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.12","groupDescription":"Social functioning, Cycle 16 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.6725","paramType":"Odds Ratio (OR)","paramValue":"1.14","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.41","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.64","groupDescription":"Social functioning, Cycle 20 Day 1","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.5780","paramType":"Odds Ratio (OR)","paramValue":"0.82","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.66","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.76","groupDescription":"Social functioning, Completion of Treatment/Early Termination Visit","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7611","paramType":"Odds Ratio (OR)","paramValue":"1.08","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.62","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.94","groupDescription":"Social functioning, Post-Treatment Follow Up 3 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.7588","paramType":"Odds Ratio (OR)","paramValue":"1.09","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.19","groupDescription":"Social functioning, Post-Treatment Follow Up 6 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1428","paramType":"Odds Ratio (OR)","paramValue":"0.60","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.41","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.39","groupDescription":"Social functioning, Post-Treatment Follow Up 9 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.9802","paramType":"Odds Ratio (OR)","paramValue":"0.99","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"0.63","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"8.70","groupDescription":"Social functioning, Post-Treatment Follow Up 12 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.1967","paramType":"Odds Ratio (OR)","paramValue":"2.34","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-69.28","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"85.94","groupDescription":"Social functioning, Post-Treatment Follow Up 18 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","pValue":"0.4795","paramType":"Difference in Proportion of Respnders","paramValue":"8.33","statisticalMethod":"Cochran-Mantel-Haenszel"},{"ciLowerLimit":"-94.30","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"100.00","groupDescription":"Social functioning, Post-Treatment Follow Up 24 Months","groupIds":["OG000","OG001"],"nonInferiorityComment":"Stratified Analysis","nonInferiorityType":"SUPERIORITY","paramType":"Difference in Proportion of Responders","paramValue":"50.00"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.9"},{"groupId":"OG001","value":"33.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"137"}],"units":"Participants"}],"title":"Physical Functioning, Presurgical/Surgery"},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.4"},{"groupId":"OG001","value":"18.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.6"},{"groupId":"OG001","value":"25.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"132"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.2"},{"groupId":"OG001","value":"36.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"123"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"45.9"},{"groupId":"OG001","value":"43.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"102"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.7"},{"groupId":"OG001","value":"42.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.0"},{"groupId":"OG001","value":"31.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"63"}],"units":"Participants"}],"title":"Physical Functioning, Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.9"},{"groupId":"OG001","value":"34.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"144"},{"groupId":"OG001","value":"131"}],"units":"Participants"}],"title":"Physical Functioning, Completion of Treatment/Early Termination Visit"},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.1"},{"groupId":"OG001","value":"39.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"97"},{"groupId":"OG001","value":"97"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 3 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.8"},{"groupId":"OG001","value":"39.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 6 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.6"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 9 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.5"},{"groupId":"OG001","value":"37.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 12 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 18 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"100"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Physical Functioning, Post-Treatment Follow Up 24 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.6"},{"groupId":"OG001","value":"40.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"137"}],"units":"Participants"}],"title":"Role Functioning, Presurgical/Surgery"},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.3"},{"groupId":"OG001","value":"22.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"title":"Role Functioning, Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"45.9"},{"groupId":"OG001","value":"33.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"134"}],"units":"Participants"}],"title":"Role Functioning, Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.4"},{"groupId":"OG001","value":"39.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"123"}],"units":"Participants"}],"title":"Role Functioning, Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"55.9"},{"groupId":"OG001","value":"47.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"102"}],"units":"Participants"}],"title":"Role Functioning, Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.1"},{"groupId":"OG001","value":"46.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"Role Functioning, Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.6"},{"groupId":"OG001","value":"52.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"63"}],"units":"Participants"}],"title":"Role Functioning, Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9"},{"groupId":"OG001","value":"39.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"131"}],"units":"Participants"}],"title":"Role Functioning, Completion of Treatment/ Early Termination Visit"},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.5"},{"groupId":"OG001","value":"40.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"97"},{"groupId":"OG001","value":"97"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 3 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.3"},{"groupId":"OG001","value":"48.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 6 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.5"},{"groupId":"OG001","value":"52.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 9 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.5"},{"groupId":"OG001","value":"54.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 12 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.0"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 18 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Role Functioning, Post-Treatment Follow Up 24 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.4"},{"groupId":"OG001","value":"33.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"137"}],"units":"Participants"}],"title":"Social Functioning, Presurgical/Surgery"},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.2"},{"groupId":"OG001","value":"25.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"title":"Social Functioning, Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.8"},{"groupId":"OG001","value":"33.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"132"}],"units":"Participants"}],"title":"Social Functioning, Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3"},{"groupId":"OG001","value":"39.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"122"}],"units":"Participants"}],"title":"Social Functioning, Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.6"},{"groupId":"OG001","value":"44.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"101"}],"units":"Participants"}],"title":"Social Functioning, Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.0"},{"groupId":"OG001","value":"44.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"Social Functioning, Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"45.8"},{"groupId":"OG001","value":"43.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"Social Functioning, Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3"},{"groupId":"OG001","value":"41.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"144"},{"groupId":"OG001","value":"130"}],"units":"Participants"}],"title":"Social Functioning, Completion of Treatment/Early Termination"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.7"},{"groupId":"OG001","value":"44.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"96"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 3 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.1"},{"groupId":"OG001","value":"35.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 6 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.5"},{"groupId":"OG001","value":"47.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 9 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.4"},{"groupId":"OG001","value":"54.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 12 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.7"},{"groupId":"OG001","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 18 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Social Functioning, Post-Treatment Follow Up 24 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.7"},{"groupId":"OG001","value":"30.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"137"}],"units":"Participants"}],"title":"Emotional Functioning, Presurgical/Surgery"},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.2"},{"groupId":"OG001","value":"35.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"132"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.1"},{"groupId":"OG001","value":"38.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"131"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.5"},{"groupId":"OG001","value":"44.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"123"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.4"},{"groupId":"OG001","value":"41.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"101"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.8"},{"groupId":"OG001","value":"42.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.6"},{"groupId":"OG001","value":"32.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"Emotional Functioning, Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.8"},{"groupId":"OG001","value":"33.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"130"}],"units":"Participants"}],"title":"Emotional Functioning, Completion of Treatment/Early Termination Visit"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.4"},{"groupId":"OG001","value":"33.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"96"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 3 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.3"},{"groupId":"OG001","value":"33.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 6 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.5"},{"groupId":"OG001","value":"34.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 9 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.4"},{"groupId":"OG001","value":"29.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 12 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.7"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 18 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Emotional Functioning, Post-Treatment Follow Up 24 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.4"},{"groupId":"OG001","value":"46.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"137"}],"units":"Participants"}],"title":"GHS/HRQoL, PresurgicalSurgery"},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.3"},{"groupId":"OG001","value":"37.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"132"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.1"},{"groupId":"OG001","value":"47.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"132"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"55.0"},{"groupId":"OG001","value":"59.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"122"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.4"},{"groupId":"OG001","value":"61.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"101"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.1"},{"groupId":"OG001","value":"58.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"59.0"},{"groupId":"OG001","value":"61.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"GHS/HRQoL, Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9"},{"groupId":"OG001","value":"53.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"130"}],"units":"Participants"}],"title":"GHS/HRQoL, Completion of Treatment/ Early Termination Visit"},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.7"},{"groupId":"OG001","value":"53.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"96"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 3 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.7"},{"groupId":"OG001","value":"41.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 6 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.5"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"38"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 9 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.6"},{"groupId":"OG001","value":"41.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 12 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.7"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 18 Months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"50.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"GHS/HRQoL, Post-Treatment Follow Up 24 Months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"157"},{"groupId":"OG001","value":"152"}],"units":"Participants"}],"description":"Clinically-meaningful improvement in patient-reported function and HRQoL during the treatment period, defined as a \\>=10-point increase from the baseline score on each of the functional (social, emotional, physical, role) and GHS/QoLscales of the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaires Core 30 (EORTC QLQ-C30).","groups":[{"description":"Participants in the primary tumor-reductive surgery group received paclitaxel, carboplatin, atezolizumab placebo IV infusion on Day 1 of each 21-day cycle for a total of 6 cycles, and bevacizumab IV infusion starting with Cycle 2 for a total of 5 cycles, followed by maintenance therapy bevacizumab with atezolizumab placebo for a total of 22 cycles of atezolizumab placebo and 21 cycles of bevacizumab. Participants in the neoadjuvant therapy group received paclitaxel, carboplatin and placebo for 6 cycles and bevacizumab for 4 cycles. Interval surgery will occur between cycles 3 and 4. Each cycle is 21 days long. After 6 cycles, participants started maintenance therapy of bevacizumab and placebo for additional 16 cycles.","id":"OG000","title":"Placebo With Paclitaxel, Carboplatin and Bevacizumab"},{"description":"Participants in the primary tumor-reductive surgery group received paclitaxel, carboplatin, atezolizumab intravenous (IV) infusion on Day 1 of each 21-day cycle for a total of 6 cycles, and bevacizumab IV infusion starting with Cycle 2 for a total of 5 cycles, followed by maintenance therapy bevacizumab with atezolizumab for a total of 22 cycles of atezolizumab and 21 cycles of bevacizumab. Participants in the neoadjuvant therapy group received paclitaxel, carboplatin and atezolizumab for 6 cycles and bevacizumab for 4 cycles. Interval surgery will occur between cycles 3 and 4. Each cycle is 21 days long. After 6 cycles, participants started maintenance therapy of bevacizumab and atezolizumab for additional 16 cycles.","id":"OG001","title":"Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab"}],"paramType":"NUMBER","populationDescription":"PRO-evaluable population is defined as patients in the ITT population with a baseline and \\>=1 post-baseline PRO assessment.","reportingStatus":"POSTED","timeFrame":"From randomization to the end of treatment/discontinuation (up to approximately 66 weeks), and during follow-up period (up to approximately 55 months). Cycle length=21 days.","title":"Percentage of Participants Who Achieve a Clinically-Meaningful Improvement in Patient-Reported Function and Health Related Quality of Life (HRQoL) - Neoadjuvant Group","type":"SECONDARY","unitOfMeasure":"Percentage of participants"}